Milk supplement to lower re-stent risk after heart attack
Part of Heart & circulation clinical trials.
This trial tests whether a special milk supplement can help prevent the stented artery from narrowing again after a first heart attack. If it works, you may reduce your need for another procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a first heart attack (STEMI) within the last 4 weeks and got a drug-coated stent.
- You are between 18 and 80 years old.
- You have no prior heart attack or stent procedure.
- You are not in severe heart failure or cardiogenic shock.
- You have no severe kidney disease or are not on dialysis.
- You do not have lactose intolerance or a milk allergy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well long-term cholesterol-lowering treatment works in people who recently had a heart attack (STEMI or NSTEMI). It may help your care team understand which patients benefit most and how treatment should be continued safely.
This trial tests if adding a protein called rhBNP (which helps the heart relax) to standard care after a heart attack and stent improves heart recovery and pumping strength over time.
This trial tests whether the supplement L-carnitine, given during a heart attack procedure, can reduce heart muscle damage. If you are having a STEMI heart attack and are getting angioplasty, you may be able to join.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This trial tests whether a medication called ranolazine can help prevent damage to tiny blood vessels in the heart after a certain type of heart attack (STEMI). You may be eligible if you recently had this kind of heart attack and had a successful procedure to open a blocked artery, but still have other blockages that can be treated with stents.
This trial looks at whether stronger cholesterol-lowering medicine can reduce the risk of future heart problems in people who already have a stent. It focuses on people who still have other mildly narrowed spots in their arteries.
Hear when a new In-stent Restenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.